Product NDC: | 0378-2063 |
Proprietary Name: | Atenolol and Chlorthalidone |
Non Proprietary Name: | atenolol and chlorthalidone |
Active Ingredient(s): | 50; 25 mg/1; mg/1 & nbsp; atenolol and chlorthalidone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-2063 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074203 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130328 |
Package NDC: | 0378-2063-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-2063-01) |
NDC Code | 0378-2063-01 |
Proprietary Name | Atenolol and Chlorthalidone |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-2063-01) |
Product NDC | 0378-2063 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | atenolol and chlorthalidone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130328 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | ATENOLOL; CHLORTHALIDONE |
Strength Number | 50; 25 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |